UiPath (NYSE:PATH) Shares Up 1.1%

UiPath Inc. (NYSE:PATH - Get Free Report) traded up 1.1% during mid-day trading on Friday . The stock traded as high as $19.88 and last traded at $19.51. 1,456,681 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 8,436,063 shares. The stock had previously closed at $19.30.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on PATH shares. Evercore ISI lifted their price objective on UiPath from $24.00 to $27.00 and gave the stock an "in-line" rating in a research report on Thursday, March 14th. Morgan Stanley upped their target price on UiPath from $17.00 to $25.00 and gave the stock an "equal weight" rating in a research report on Thursday, March 14th. Wells Fargo & Company boosted their price target on shares of UiPath from $24.00 to $25.00 and gave the company an "equal weight" rating in a research note on Thursday, March 14th. Truist Financial reaffirmed a "buy" rating and issued a $32.00 price objective on shares of UiPath in a research note on Wednesday, March 20th. Finally, DA Davidson lifted their price objective on shares of UiPath from $20.00 to $24.00 and gave the company a "neutral" rating in a report on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat.com, UiPath has a consensus rating of "Moderate Buy" and a consensus target price of $27.41.

UiPath Stock Up 0.9 %

The company has a market capitalization of $11.08 billion, a PE ratio of -114.76 and a beta of 1.01. The stock's fifty day moving average price is $21.83 and its two-hundred day moving average price is $21.63.

UiPath (NYSE:PATH - Get Free Report) last issued its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.10. The business had revenue of $405.25 million during the quarter, compared to analyst estimates of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. On average, equities research analysts forecast that UiPath Inc. will post -0.04 EPS for the current year.

Insider Activity

In other news, CFO Ashim Gupta sold 16,000 shares of the business's stock in a transaction on Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the sale, the chief financial officer now owns 87,505 shares in the company, valued at approximately $1,998,614.20. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders sold a total of 72,000 shares of company stock worth $1,591,360 in the last quarter. 31.03% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in PATH. GSA Capital Partners LLP increased its holdings in shares of UiPath by 150.3% during the first quarter. GSA Capital Partners LLP now owns 26,054 shares of the healthcare company's stock valued at $591,000 after acquiring an additional 15,644 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S lifted its stake in UiPath by 10,718.8% during the 1st quarter. BI Asset Management Fondsmaeglerselskab A S now owns 42,518 shares of the healthcare company's stock valued at $964,000 after acquiring an additional 42,125 shares during the period. Daiwa Securities Group Inc. raised its holdings in shares of UiPath by 5.4% during the first quarter. Daiwa Securities Group Inc. now owns 25,400 shares of the healthcare company's stock valued at $576,000 after purchasing an additional 1,300 shares during the last quarter. Greenwood Capital Associates LLC bought a new position in UiPath during the first quarter valued at approximately $235,000. Finally, Janney Montgomery Scott LLC boosted its holdings in UiPath by 27.2% in the first quarter. Janney Montgomery Scott LLC now owns 89,340 shares of the healthcare company's stock worth $2,025,000 after purchasing an additional 19,126 shares during the last quarter. Hedge funds and other institutional investors own 62.50% of the company's stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.